dela Peña, Ike
Borlongan, Cesar V.
Funding for this research was provided by:
National Institute of Neurological Disorders and Stroke (1R21NS089851-01)
National Institute of Neurological Disorders and Stroke (1R01NS071956-01A1)
James and Esther King Biomedical Research Foundation (1KG01-33966)
Article History
Received: 18 August 2015
Revised: 5 October 2015
Accepted: 8 October 2015
First Online: 20 October 2015
Compliance with Ethical Standards
:
: This article does not contain studies with human participants or animals performed by any of the authors.
: This study was supported, in part, by the National Institutes of Health National Institute of Neurological Disorders and Stroke 1R01NS071956-01A1, 1R21NS089851-01, James and Esther King Biomedical Research Foundation 1KG01-33966, and Loma Linda University School of Pharmacy.
: C. V. Borlongan has patents and patent applications on stem cell therapy. I. dela Peña declares that he has no conflict of interest.